We are monitoring the impact of COVID-19 on Latin America Viscosupplementation Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 11413
Share on
Share on

Latin America Viscosupplementation Market Research Report – Segmented By Product, End-user, and Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 11413
Pages: 100

Latin America Viscosupplementation Market Size (2021 to 2026)

The Latin America Viscosupplementation market size is forecasted to grow steadily during the forecast period.

In recent decades, the Latin American health community or governments have increasingly prioritized treating various chronic diseases, even in low- and middle-income countries. As a result, the demand for appropriate treatments and cures has increased dramatically to address the global burden of osteoarthritis, leading to an increase in the use and uptake of viscosupplementation. In addition, other factors, such as smoking and a poor diet, are the cause of osteoarthritis in the younger generation.

The Latin American viscosupplementation market is largely driven by increasing patient awareness of new treatments for osteoarthritis. The increasing prevalence and incidence of osteoarthritis are accelerating the growth of the market. The increase in the obese population in the world and the increase in the geriatric population are also important factors for the market's growth. Growing awareness of the benefits of minimally invasive osteoarthritis surgical procedures is one of the key factors driving the growth of the Viscosupplementation Market.

In recent years, with the shift to value-based care, hospitals and healthcare systems face extreme competition from outpatient service sites, especially those offering in-office procedures and outpatient surgery. Gaining popularity worldwide, ambulatory care facilities offer cost-effective and operational efficiencies, facilitating patient access, highly competitive pricing, and increased opportunities for physician participation in the market. Hence, due to all the factors mentioned above, the studied market is expected to increase in the future.

The lack of safety and efficacy associated with viscosupplementation products poses significant challenges for the Latin American viscosupplementation market. Complex regulatory processes and clinical trials for developing viscosupplementation products can slow down the market as it takes a long time to get a product approved by regulatory bodies. In addition, reimbursement policies associated with treatment vary from country to country, and so this can also pose challenges for the market.

COVID-19 Impact on the Latin America Viscosupplementation market:

The Latin American viscosupplementation market is expected to experience massive market growth after the COVID-19 pandemic. Furthermore, with the growing popularity of organized sports, sports injury incidents have also increased. For example, according to a recent publication from the Department of Health and Human Services, approximately 2.5 million sports injuries occur each year. Hence, the considerable increase in sports injury incidents is expected to increase the demand for orthopedic treatments, ultimately providing significant growth opportunities for the global viscosupplementation market in the coming years.

In addition, to strengthen the presence in the Latin American market, various emerging and well-established companies operating in the viscosupplementation market are adopting several business strategies such as strategic collaborations and product development. Furthermore, to gain the trust and loyalty of customers, industry players are opting for such strategies to grow after the pandemic period.

This market research report on the Latin American viscosupplementation market has been segmented and sub-segmented into the following categories.

By Product:

  • Single Injection
  • Three Injection
  • Five Injection

By End-Use:

  • Hospitals
  • Orthopedic Clinic/ Ambulatory Surgical Centers (ASCs)

By Country:

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Geographically, the Latin America Viscosupplementation market is expected to experience strong growth during the forecast period 2020-2028, owing to the increase in healthcare spending. Additionally, low manufacturing costs in Mexico and Chile have led to an increase in production facilities, attracting pharmaceutical and biotech giants to the Latin American region from around the world.

The increasing incidence of rheumatoid arthritis is also expected to drive the market growth in the Brazil region during the forecast period. For example, according to the Institute for Health Metrics and Evaluation, the number of rheumatoid arthritis cases increased from 83,200 in 2009 to 93,365 in 2019 in Brazil alone. Therefore, considering the number of cases in other major countries in the Latin American region, the healthcare business related to the treatment of rheumatoid arthritis will drive the market growth for the upcoming years.

KEY MARKET PLAYERS:

Sanofi S.A., Zimmer Biomet Holdings Inc., Bioventus LLC, Anika Therapeutics Inc., Fidia Farmaceutici S.p.A., Ferring B.V., Seikagaku Corporation, Chungai Pharmaceutical Co., Ltd., OrthogenRx Inc., and Mylan N.V. are some of the companies operating in the Latin American Viscosupplementation market.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Product
      1. Single Injection
      2. Three Injection
      3. Five Injection
      4. Y-o-Y Growth Analysis, By Product
      5. Market Attractiveness Analysis, By Product
      6. Market Share Analysis, By Product
    2. By End-User
      1. Hospitals
      2. Orthopedic Clinic/ Ambulatory Surgical Centers (ASCs)
      3. Y-o-Y Growth Analysis, By End-User
      4. Market Attractiveness Analysis, By End-User
      5. Market Share Analysis, By End-User
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Product
        3. By Distribution Channel
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Product
        3. By Distribution Channel
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Product
        3. By Distribution Channel
    2. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Sanofi S.A.
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Zimmer Biomet Holdings Inc.
    3. Bioventus LLC
    4. Anika Therapeutics Inc.
    5. Fidia Farmaceutici S.p.A.
    6. Ferring B.V.
    7. Seikagaku Corporation
    8. Chungai Pharmaceutical Co., Ltd.
    9. OrthogenRx Inc.
    10. Mylan N.V
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures 
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of product and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Latin America Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  2. Latin America Single Injection Market, By Region, From 2021 to 2026 (USD Million)
  3. Latin America Three Injection Market, By Region, From 2021 to 2026 (USD Million)
  4. Latin America Five Injection Market, By Region, From 2021 to 2026 (USD Million)
  5. Latin America Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  6. Latin America Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  7. Latin America Orthopedic Clinic/ Ambulatory Surgical Centers (ASCs) Market, By Region, From 2021 to 2026 (USD Million)
  8. Brazil Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  9. Brazil Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  10. Argentina Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  11. Argentina Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  12. Mexico Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  13. Mexico Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)
  14. Rest of Latin America Viscosupplementation Market, By Product, From 2021 to 2026 (USD Million)
  15. Rest of Latin America Viscosupplementation Market, By End-User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample